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OR I G I N A L R E S E A R CH
Pulmonary hypertension is a manifestation of congestive
heart failure and left ventricular diastolic dysfunction
in octogenarians with severe aortic stenosis
Amresh Raina,1 Zachary M. Gertz,2 William T. O’Donnell,3 Howard C. Herrmann,3 Paul R. Forfia4
1Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA; 2Division of Cardiology, Virginia Commonwealth University, Richmond,
Virginia, USA; 3Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; 4Division of Cardiology, Temple University
Hospital, Philadelphia, Pennsylvania, USA
Abstract: Previous studies have suggested that pulmonary hypertension (PH) in severe aortic stenosis (AS) is a risk factor for operative
mortality with aortic valve replacement (AVR). Conversely, others have shown that patients with AS and PH extract a large symptomatic and
survival beneﬁt from AVR compared with those patients not treated surgically. We sought to evaluate the prevalence, severity, and mechanism
of PH in an elderly patient cohort with severe AS. We prospectively evaluated 41 patients aged ≥80 years with severe AS. All patients underwent
cardiac catheterization and transthoracic echocardiography within 24 hours. We found that PH was common in this cohort: 32 patients (78%)
had PH; however, the predominant mechanism of PH was left heart congestion. Patients with PH had nearly double the pulmonary artery
wedge pressure of patients without PH (23 vs. 13 mmHg; P ≤ 0.001). In patients with PH compared with those without, pulmonary vascular
resistance was higher yet still under 3 Wood units (WU; 2.9 vs. 1.5 WU; P = 0.001), and the transpulmonary gradient (11 vs. 7 mmHg; P =
0.01) and diastolic pulmonary gradient (DPG; 3.0 vs. 2.7 mmHg; P = 0.74) were in normal range. Left ventricular diastolic abnormalities were
more common in patients with severe AS and PH. Right ventricular (RV) dysfunction was common (13/41 patients, 32%), but the PH and non-
PH groups had similar tricuspid annular plane systolic excursion (2.0 vs. 2.3 cm; P = 0.15). Only 2 subjects had both RV dysfunction and an
elevated DPG. In conclusion, PH is common in elderly patients with severe AS. This occurs largely due to left heart congestion, with a relative
absence of pulmonary vascular disease and RV dysfunction, and as such, PH may serve as a heart failure equivalent in these patients.
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Severe aortic stenosis (AS) is encountered with increasing frequency
in industrialized nations. This is in part due to aging population de-
mographics but also may be due to increased awareness of the diag-
nosis in light of emergence of transcatheter aortic valve replacement
(TAVR).1-3
In patients with severe AS, signiﬁcant pulmonary hypertension
(PH) has often been considered a relative contraindication to AVR
as a result of increased operative mortality.4-7 However, other stud-
ies have shown that patients with severe AS and PH extract a signif-
icant symptomatic and survival beneﬁt with AVR compared to those
patients treated medically.8,9
Importantly, PH is common in adult patients with severe AS,
with prevalence ranging between 25% and 65%.4,10-12 However, it
should be noted that most studies evaluating the prognosis of pa-
tients with PH and severe AS have used Doppler-estimated pul-
monary artery systolic pressures (PASPs) obtained via tricuspid
regurgitant (TR) jet velocity from transthoracic echocardiogra-
phy (TTE), which may both under- and overestimate the presence
of PH.13 In addition to accuracy limitations, Doppler-estimated PASP
alone does not provide insight into the hemodynamic mechanism of
PH in any given patient or the presence or absence of an elevated
pulmonary vascular resistance (PVR) and right ventricular (RV) dys-
function, all of which likely better inform regarding a patient’s PH-
related risk with valvular intervention.
The few studies to use invasive hemodynamic assessment to char-
acterize PH in patients with severe AS typically evaluated younger
patients (before the TAVR era), and the physiology of PH in elderly
patients being evaluated for TAVR might be quite different from that
in younger cohorts, as elderly patients often have a variety of risk
factors for PH aside from AS, such as systemic hypertension, renal
dysfunction, sleep apnea, and left ventricular (LV) diastolic dysfunc-
tion. Importantly, prior invasive hemodynamic studies did not simul-
taneously evaluate LV structure, systolic and diastolic parameters, or
RV function in patients with and without PH.10-12
This study was therefore designed with the following aims:
(1) to evaluate the prevalence of PH based on both invasive he-
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modynamic assessment and TTE in an elderly cohort with severe
AS, (2) to determine the predominant mechanism of PH in these pa-
tients and ﬁnd associations between invasive hemodynamics and
LV systolic and diastolic abnormalities on TTE, and (3) to evaluate
for the presence of RV dysfunction and elevated PVR in patients
with and without PH.
METHODS
All patients aged 80 years and older referred for cardiac catheteriza-
tion at the University of Pennsylvania over a 6-month period to
assess AS of at least moderate severity in consideration of TAVR
evaluation were screened for enrollment in this study. Patients were
excluded if they had a bicuspid aortic valve, moderate or greater
aortic regurgitation, severe mitral regurgitation or stenosis, severe
oxygen-dependent chronic obstructive pulmonary disease, or prior
aortic or mitral valve surgery or were hemodynamically unstable.
The protocol was approved by the University of Pennsylvania In-
stitutional Review Board (IRB approval 811936), and all patients
provided written informed consent.
Echocardiography
Standard 2-dimensional (2D) and Doppler TTEs were obtained us-
ing Philips IE33 machines (Philips Medical Systems) within 24 hours
of invasive hemodynamic assessment. LV dimensions, LV wall thick-
ness, and left atrial anterior-posterior dimensions were measured
from the parasternal long-axis view in 2D in standard fashion. Left
ventricular outﬂow tract (LVOT) dimension was measured in 2D
in the parasternal long-axis view in midsystole. Peak and mean aortic
valve gradients were measured using continuous-wave Doppler (in-
cluding use of a Pedoff nonimaging continuous-wave probe) from
standard echocardiographic views. In addition, LVOT and aortic
valve velocity time integrals (VTIs) were measured in all patients.
For those in atrial ﬁbrillation, an average of 5 cycles was used.
LV ejection fraction (LVEF) was calculated using the biplane
Simpson method of disks. Pulse wave (PW) Doppler of mitral valve
inﬂow was used as a measure of LV diastolic function. RV systolic
function was measured using tricuspid annular plane systolic excur-
sion (TAPSE) via the M-mode of the tricuspid annulus. In addition,
PASP was estimated using TR jet velocity added to an estimate of
right atrial pressure per American Society of Echocardiography
guidelines.14 PH based on TTE assessment was deﬁned as esti-
mated PASP >40 mmHg. Last, the VTI of the PW spectral Dopp-
ler signal in the RV outﬂow tract (RVOT) was measured from
parasternal short-axis views in all patients, and the presence of Dopp-
ler notching of this PW signal was also assessed in all patients.15
Cardiac catheterization
All patients underwent right and left heart catheterization via a stan-
dard femoral approach using 6-French catheters. Aortic valve gra-
dients were measured using a ﬂuid-ﬁlled, dual-lumen pigtail catheter
with simultaneous measurement from the left ventricle and proximal
ascending aorta. For patients in atrial ﬁbrillation, an average of 5 cy-
cles was used with AV gradients and hemodynamic measurements.
All hemodynamic measurements were collected within 3 minutes of
valve gradient assessment at end expiration. PH was deﬁned as mean
PApressures >25mmHg.Oxygen consumption (V
:
O2) was directlymea-
sured using an Ultima CardiO2 breathing analyzer (Medgraphics).
Statistical analysis
Patients were classiﬁed as having PH–right heart catheterization (PH-
RHC) or no PH–right heart catheterization (NoPH-RHC) on the ba-
sis of invasive hemodynamics. Demographic, clinical, hemodynamic,
and echocardiographic variables were compared between the PH-
RHC group and the NoPH-RHC group. In addition, in the PH-
RHC group, we evaluated the performance of Doppler-estimated
PASP in correctly identifying patients with PH. Continuous variables
were compared with a t test, using a paired-samples technique where
appropriate. Discrete variables were compared using the Fisher exact
test. All signiﬁcance tests were 2-sided, and P < 0.05 was considered
signiﬁcant.
RESULTS
Forty-one patients (mean age: 86 ± 5 years) with severe AS (aortic
valve area: 0.72 cm2) were enrolled in the study. Clinical and demo-
graphic characteristics of the overall cohort and those with and
without PH characterized by invasive hemodynamic assessment are
shown in Table 1. PH was common in this cohort: 32 patients (78%)
met criteria for PH on hemodynamic assessment.
Table 1. Clinical and demographic characteristics of the
study cohort
Overall
(n = 41)
PH-RHC
(n = 32)
NoPH-
RHC
(n = 9) P
Age, mean ± SD,
years 86 ± 5 86 ± 5 86± 4 0.70
Male, % 49 47 56 0.72
Weight,
mean ± SD,
pounds 166 ± 39 165 ± 39 168± 41 0.85
BSA, mean ±
SD, m2 1.8 ± 0.3 1.8 ± 0.2 1.8 ± 0.3 0.84
HTN, % 73 75 67 0.68
Heart failure, % 88 91 78 0.29
Syncope, % 20 16 33 0.34
Angina, % 22 22 22 0.65
CAD, % 63 66 56 0.70
DM, % 10 19 22 0.99
PAD, % 17 22 0 0.31
Aﬁb, % 39 44 22 0.44
Note: Aﬁb: atrial ﬁbrillation; BSA: body surface area; CAD:
coronary artery disease; DM: diabetes mellitus; HTN: hyperten-
sion; NoPH-RHC: no pulmonary hypertension–right heart cathe-
terization; PAD: peripheral arterial disease; PH-RHC: pulmonary
hypertension–right heart catheterization; SD: standard deviation.
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Patients in the PH-RHC group were similar to those in the NoPH-
RHC group in terms of age, sex, weight, and body surface area.
Though patients with PH more commonly had systemic hyperten-
sion, symptoms of heart failure, prior history of coronary artery dis-
ease, and history of atrial ﬁbrillation, these differences were not
statistically signiﬁcant compared with NoPH-RHC patients in this
cohort (Table 1).
Hemodynamic characteristics of the study groups are shown in
Table 2. Most PH-RHC patients (72%) had mild or moderate PH
(deﬁned as PASP 40–59 mmHg), while 28% had severe PH (deﬁned
as PASP ≥60 mmHg).
The predominant mechanism of PH in this cohort was left heart
congestion. Patients in the PH-RHC group had nearly double the pul-
monary artery wedge pressure (PAWP) of patients in the NoPH-
RHC group, with a higher PVR that was still under 3 Wood units
(WU). The transpulmonary gradient (TPG) and diastolic pulmo-
nary gradient (DPG) were both in the normal range in the PH-
RHC and NoPH-RHC groups. The ratio of RA pressure to PAWP
was also similar between the PH-RHC group and the NoPH-RHC
group, as was PVR/systemic vascular resistance ratio (Table 2). Of
the 14 patients in the PH group with PVR >3 WU, 10 patients
(71%) had normal DPG ≤7 mmHg. Mean DPG in the PVR >3 WU
group was 5.4 mmHg.
Echocardiographic characteristics of the study cohort are illus-
trated in Table 3. PASP estimated by TTE was signiﬁcantly higher
in the PH-RHC group than in the NoPH-RHC group. However,
TTE underestimated the degree of PH relative to RHC in the PH-
RHC patients. Moreover, if we used only TTE, 10 patients (31%) in
the PH-RHC group would have been misclassiﬁed as not having
PH if using TTE alone, though none of these patients had severe
PH. Patients in the PH-RHC group had more LV hypertrophy, higher
mitral E wave velocities, and higher E/A ratios, in keeping with LV
diastolic dysfunction and elevated LV ﬁlling pressure. LV diastolic
dimension and LVEF were not signiﬁcantly different in patients with
PH compared with patients without PH (see Table 3).
In the overall cohort, 13 patients (32%) had evidence of RV dys-
function (deﬁned as TAPSE <1.8 cm), yet the average TAPSE value
was not signiﬁcantly different between the PH-RHC group and the
NoPH-RHC group. Figure 1 illustrates the interactions of TAPSE
and PVR and of TAPSE and DPG in patients with PH. Most patients
Table 2. Invasive hemodynamic characteristics of the study cohort
Overall
cohort
(n = 41)
PH-RHC
(n = 32)
NoPH-
RHC
(n = 9) P
RAP, mmHg 9 ± 4 10 ± 4 7 ± 3 0.01
PA systolic
pressure,
mmHg 47 ± 15 52 ± 12 29 ± 5 <0.001
PA diastolic
pressure,
mmHg 23 ± 7 25 ± 6 16 ± 3 <0.001
Mean PA,
mmHg 31 ± 9 34 ± 8 20 ± 3 <0.001
PAWP, mmHg 21 ± 7 23 ± 6 13 ± 4 <0.001
TPG, mmHg 10 ± 5 11 ± 5 7 ± 4 0.01
DPG, mmHg 2.9 ± 3.3 3.0 ± 3.4 2.7 ± 2.8 0.74
RAP/PAWP
ratio 0.45 ± 0.15 0.44 ± 0.15 0.50 ± 0.13 0.32
Cardiac output,
L/min 4.2 ± 1.2 4.1 ± 1.2 4.5 ± 1.2 0.47
PVR, WU 2.6 ± 1.5 2.9 ± 1.5 1.5 ± 0.8 0.001
SVR, WU 23 ± 7 24 ± 8 21 ± 7 0.34
PVR/SVR
ratio 0.11 ± 0.07 0.12 ± 0.07 0.07 ± 0.05 0.05
Aortic valve
area, cm2 0.71 ± 0.31 0.69 ± 0.29 0.77 ± 0.37 0.53
Aortic peak
gradient,
mmHg 37 ± 22 36 ± 23 41 ± 20 0.48
Aortic mean
gradient,
mmHg 44 ± 17 44 ± 17 46 ± 15 0.72
Note: DPG: diastolic pulmonary gradient; NoPH-RHC: no pul-
monary hypertension–right heart catheterization; PA: pulmonary ar-
tery; PAWP: pulmonary artery wedge pressure; PH-RHC: pulmonary
hypertension–right heart catheterization; PVR: pulmonary vascular
resistance; RAP: right atrial pressure; SVR: systemic vascular resis-
tance; TPG: transpulmonary gradient; WU: Wood units.
Table 3. Echocardiographic characteristics of the study cohort
Overall
cohort
(n = 41)
PH-RHC
(n = 32)
NoPH-
RHC
(n = 9) P
LVEF, % 58 ± 17 56 ± 18 64 ± 11 0.12
LV EDD, cm 4.42 ± 0.98 4.38 ± 1.0 4.59 ± 0.68 0.47
LV PW
Doppler, cm 1.36 ± 0.67
1.43 ±
0.74 1.12 ± 0.21 0.046
LA size, mm 43 ± 8 44 ± 8 39 ± 8 0.15
E wave velocity,
m/s 1.06 ± 0.41 1.13 ± 0.4 0.79 ± 0.15 0.001
E/A ratio 1.07 ± 0.57 1.21 ± 0.6 0.7 ± 0.1 0.001
TAPSE, cm 2.0 ± 0.5 2.0 ± 0.5 2.3 ± 0.5 0.15
RVOT VTI, cm 15 ± 3.5 14 ± 3 18 ± 3 0.02
RVOT Doppler
notching, % 25 31 0 0.29
Acceleration
time, ms 101 ± 22 100 ± 24 104 ± 14 0.57
Note: EDD: end diastolic dimension; LA: left atrium; LV: left
ventricular; LVEF: left ventricular ejection fraction; NoPH-RHC:
no pulmonary hypertension–right heart catheterization; PH-RHC:
pulmonary hypertension–right heart catheterization; PW: pulse wave;
RVOT: right ventricular outﬂow tract; TAPSE: tricuspid annular plane
systolic excursion; VTI: velocity time integral.
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with PH fell into the normal-TAPSE, low-PVR quadrant, whereas
only 9 patients (28%) had both elevated PVR and RV dysfunction.
More importantly, however, only 2 patients had RV dysfunction and
an elevated DPG.
The RVOT VTI was lower in patients in the PH-RHC group
than in the NoPH-RHC group (see Table 3). Notching of the PW
Doppler proﬁle in the RVOT was uncommon in the PH-RHC group
and completely absent in the NoPH-RHC group, and RVOT acceler-
ation time was similar in both groups, in keeping with overall normal
PVR. Midsystolic notching and RVOT acceleration time <80 ms cor-
rectly identiﬁed both patients with PVR >5 WU.
DISCUSSION
In this study, we demonstrated that PH was present in the vast ma-
jority of elderly patients with severe AS and is typically a reﬂection
of worsened left heart congestion and LV diastolic dysfunction, with
a relative absence of pulmonary vascular remodeling. Severe calciﬁc
AS is most commonly encountered in elderly patients, and even the
very elderly are increasingly being evaluated for valvular interven-
tion and given less invasive and even percutaneous aortic valve
replacement.16,17 Likewise, PH is prevalent in the setting of severe
AS, with prior literature showing that PH is associated with increased
perioperative risk and also that patients with PH and severe AS ex-
tract a large symptomatic and survival beneﬁt from AVR.4-9
The former observation could suggest that PH itself is the cause
of increased risk in the setting of AVR. However, such observa-
tions may also reﬂect the fact that elderly patients with AS often
have a variety of comorbid conditions that are also associated with
PH (i.e., systemic hypertension, arteriosclerosis, coronary artery dis-
ease, chronic kidney disease, sleep apnea), and it is these factors and
not PH per se that convey risk in this setting.18,19
The latter observation is likely explained by the high prevalence
of left-sided heart failure (HF) in severe AS, a powerful adverse
prognostic factor in AS offset by corrective valve surgery.20 There-
fore, it is critically important to distinguish the mechanism of PH
in the setting of severe AS.
Our study is the ﬁrst, to our knowledge, to rigorously evaluate
the prevalence and mechanisms of PH in an elderly cohort with
severe AS by using concomitant invasive hemodynamic assessment
and echocardiographic-Doppler assessment. Our ﬁndings conﬁrm that
Figure 1. Scatterplot of tricuspid annular plane systolic excursion (TAPSE) versus pulmonary vascular resistance (PVR; top) and diastolic
pulmonary gradient (DPG; bottom). WU: Wood units.
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PH is very commonly encountered in elderly patients with AS, with a
prevalence at 78%, which is even higher than reported in previously
studied younger cohorts.4,10-12
In terms of the mechanism of PH in these patients, previous he-
modynamic studies have reported varied ﬁndings. Silver et al.12 eval-
uated 45 patients with severe AS and found only 13 patients (29%) to
have PH, based on PASP >50 mmHg. In this study, patients with PH
had lower LVEF and cardiac index. Interestingly, most of these
patients also had elevated TPG, implying a reactive component of
component of pulmonary vascular remodeling.
Faggiano et al.10 studied a larger cohort of 388 younger AS pa-
tients (mean age: 67 years) characterized by hemodynamic evalua-
tion. In their study, PH was more prevalent, with 75% of patients
having some degree of PH. PA pressures correlated most strongly
with left ventricular end diastolic pressure and PAWP. There was
no signiﬁcant correlation between PH and LVEF in their study.
TPG was again higher in patients with PH, especially those with
severe PH.
In our elderly cohort, elevated left heart pressures were the pre-
dominant driver of PH. Interestingly, RA pressure to PAWP ratio
was relatively low and in fact lower in the patients with PH than in
those without PH, again suggesting a high burden of left heart con-
gestion and a relative absence of disproportionate right heart failure
in these patients. TPG was higher in patients with PH but still over-
all in the normal range, while DPG was similar and normal in both
groups, and even those patients with PVR >3 WU typically had nor-
mal DPG.
In addition, our study also demonstrated signiﬁcant differences
in LV structure, with more left ventricular hypertrophy and a greater
degree of diastolic dysfunction in patients with PH, conﬁrming the
hemodynamic ﬁndings. In keeping with a lack of difference in car-
diac index between patients with and without PH, we did not ﬁnd a
signiﬁcant association between PH and LV systolic function. More-
over, while RV dysfunction was relatively common in this cohort
(32%), TAPSE values were similar in the PH and non-PH groups.
Moreover, even among patients with PH, the prevalence of pa-
tients with RV dysfunction and elevated PVR was relatively low,
while the presence of RV dysfunction and an elevated DPG was
rare. Thus, the combined presence of RV dysfunction and true pul-
monary vascular disease, which should embody a higher-risk PH
population, was distinctly uncommon. Finally, though TTE under-
estimated the prevalence of PH, echocardiographic-Doppler esti-
mates of PVR were able to correctly identify patients with severely
elevated PVR.
Limitations
Our study has several important limitations. Because of the careful
and rigorous requirement for TTE and invasive hemodynamic as-
sessment within 24 hours, our sample size was relatively small, and
this may have been responsible for a lack of statistical signiﬁcance
in some variables, particularly in terms of clinical and demographic
variables. Though we collected clinical data on typical risk factors
for PH, not all patients had a detailed evaluation for other etiolo-
gies of PH such as chronic thromboembolic PH or PH related to
chronic lung disease such as chronic obstructive pulmonary dis-
ease, although no patients were oxygen dependent in this study. In
addition, though patients with severe mitral stenosis or regurgita-
tion or prior mitral surgery were excluded, we did not quantitatively
assess mitral regurgitation in our cohort.
Conclusions
In summary, the predominance of left-sided congestion and absence
of pulmonary vascular disease by hemodynamics, the greater bur-
den of left-sided structural heart disease and diastolic dysfunction
by echocardiographic-Doppler exam, and the relatively low inci-
dence of concomitant RV dysfunction and elevated PVR speak to
the fact that in most elderly subjects with PH, the PH represents a
left-sided HF equivalent in the setting of severe AS in these patients.
This concept has several implications with regard to the assessment
and management of elderly patients with severe AS and PH. First,
in those elderly patients with severe AS and PH not felt to be sur-
gical or TAVR candidates, cautious management of preload and
afterload might decrease left heart congestion, reduce PA pressures,
and hopefully lead to symptomatic improvement. A similar strategy
might be employed to medically optimize elderly patients with AS
and PH prior to surgical AVR or TAVR therapy, weighing the
risks of medical management with the delay to their deﬁnitive in-
tervention. Last, we hypothesize that elderly patients with severe
AS and PH would obtain a signiﬁcant symptomatic beneﬁt from
AVR and that over time their PA pressures would decrease.
A recent published report from the FRANCE 2 TAVR registry
serves to support this notion. In the French registry, patients with
PH had no difference in 30-day mortality or major adverse cardio-
vascular events after TAVR. Patients with PH did have higher
1-year mortality than patients without PH, but functional status
and symptoms improved after TAVR regardless of PA pressure.8
Similarly, Sinning et al.21 reported that a reduction in PA pressure
after TAVR was associated with improvement in 2-year mortality.
Ultimately, we hypothesize that PH, as a left-sided HF equivalent,
may represent more of an indication rather than a contraindication
for valvular intervention, including TAVR, in most elderly patients
with severe AS, though larger prospective studies are clearly war-
ranted to assess outcomes postvalvular intervention in this popula-
tion.
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